Today (2017 C.E. - 2025 C.E.)

This archive spans the years 2017 through 2025, a period marked by rapid advances in clean energy, medicine, technology, and social equity. It collects documented breakthroughs, policy wins, and scientific achievements from the present era. If you want evidence that progress is real and ongoing, this is where to look.

Electric buses, for article on Kenya electric buses

Kenya is producing its first electric buses

Electric buses are now being assembled in Kenya for the first time, marking a genuine shift in how East Africa thinks about clean public transit. A Nairobi startup called BasiGo partnered with a veteran Mombasa assembler to build 1,000 electric buses over three years — creating over 600 jobs in manufacturing, maintenance, and charging. What makes this especially promising is BasiGo’s pay-per-kilometer financing model, which makes electric buses as affordable upfront as diesel for everyday operators. Kenya’s already-clean electricity grid means these buses will run on genuinely green power. It’s a hopeful template other African cities could follow.

Vials and syringes in a lab, for article on not-for-profit drug access

Pfizer to sell all its drugs in 45 low-income countries at non-profit price

Pfizer’s not-for-profit pricing pledge now spans all 500 of its medicines — including chemotherapy and oral cancer treatments — across 45 of the world’s lowest-income countries. That’s a major expansion of an accord the company launched in 2022, which originally covered only patented drugs. By including off-patent medicines too, Pfizer is acknowledging that even decades-old cancer treatments often remain out of reach where generic supply chains never took hold. For patients across much of sub-Saharan Africa and South Asia, where cancer and heart disease are rising fast, this could quietly move the floor on what’s possible. And when the world’s largest drugmaker makes a move this broad, the rest of the industry tends to notice.